Healthcare Capacity & Research in Botswana

Partnership objective

Train healthcare workers in Botswana. 

A new extended release mechanism for this ARV is being evaluated which will hopefully benefit women suffering from HIV/AIDS in Botswana. A new extended release mechanism for this ARV is being evaluated which will hopefully benefit women suffering from HIV/AIDS in Botswana. Copyright GSK/IAVI

Description of partnership activities and how they address needs and challenges

Opened in 2005, the Boehringer Ingelheim Training and Facilitation Unit in Gaborone, Botswana trains general practitioners, physicians, occupational health specialists, nurses, pharmacists, pharmacy technicians, medical store managers, healthcare managers and health ministry officials. Since its foundation in 2005, some 7,100 attendees have taken part in training activities at the unit. Working with partners such as Harvard University, the US Centers for Disease Control & Prevention and the WHO, it provides continuing medical education workshops, courses and lectures on the management of acute myocardial infarction, hypertension, diabetes, asthma and HIV/AIDS, along with Good Clinical Practice, leadership training, customer relations, pediatric care, biopharmaceuticals and pharmacovigilance,. It also undertakes public health awareness and education programs (see separate program entry in Chronic Disease section), and hosts meetings of the Botswana Medical Society, the HIV Clinician Society, the Pharmaceutical Society of Botswana and other associations.

The Boehringer Ingelheim Endowed Chair in Clinical Pharmacology was set up in 2009 and helps to raise the status of health professionals and facilitates the provision of vital training to young interns and doctors, helping to advance the fight against HIV/AIDS in Botswana. It helps to lay the foundations for the Botswana Medical School, opened in 2013.

In 2006, the first pharmacy student from Botswana started at Rhodes University, Grahamstown, South Africa under a Botswana government program funded by Boehringer Ingelheim. Beneficiaries are required to work in the public sector after completing their studies.

Boehringer Ingelheim South Africa established a partnership with the Government of Botswana to build an infectious disease care clinic (IDCC) at Gumare, a small rural village on the outskirts of the Okavango Delta in Botswana. The clinic, officially opened in 2007, serves the community for general healthcare requirements and the Anti-retroviral (ARV) Clinic Sponsorship helps to overcome the ARV treatment bottlenecks in this area.

HIV/AIDS has a major impact on health in Botswana and Boehringer Ingelheim currently runs two clinical trials there for its nevirapine ARV. A new extended release mechanism for this ARV is being evaluated which will hopefully benefit women suffering from HIV/AIDS in Botswana. The first HIV study was initiated in 2008. Boehringer Ingelheim’s ongoing clinical trial work in Botswana also addresses hypertension, diabetes, myocardial infarction and stroke, which are major causes of morbidity and mortality in the country. Boehringer Ingelheim was the first company to identify and train private practitioners to conduct clinical trials in Botswana, while at the same time bringing important research work to the Princess Marina Hospital and other medical centers.

Partnership information

Company(ies) Boehringer Ingelheim

Partner(s) Botswana Ministry of Health, Center for Disease Control and Prevention (CDC), Harvard University, University of Botswana, World Health Organization (WHO)

Type of Partner(s) Academia / Hospitals, Government, IGOs

Therapeutic Focus Non-Communicable Diseases, Infectious Diseases

Disease(s) Cardiovascular Diseases, Diabetes, HIV/AIDS, Hypertension

Program Type(s) Health System Infrastructure - Development of Physical Infrastructure, Health System Infrastructure - Training

Targeted Population(s) Health professionals, Patients in needs of treatment, People with low income

Region(s) Sub-Saharan Africa

Number of Countries 1

Country(ies) Botswana

Start Date 2005

Completed date 2013